XenoTherapeutics is a not-for-profit, clinical-stage regenerative medicine company developing innovative cell and tissue-based research solutions.
Our FDA-accepted pathogen screening and validated assays provide a robust regulatory pathway for the clinical advancement of xenogeneic cells, tissues, and organs.
We accelerate the development, testing, training, and commercialization of innovative, live biotherapeutic products that deliver on the promise of regenerative medicine.
Company Details
- Employees
- 13
- Founded
- 2016
- Address
- 359 Newbury Street,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- xenotherapeutics.org
- Keywords
- Translational Medicine, Regenerative Medicine, Xenotransplantation, Biotechnology, Cell Therapy, Transplantation.
- HQ
- Boston, Massachusetts
Xenotherapeutics Questions
Xenotherapeutics's website is xenotherapeutics.org
Xenotherapeutics's LinkedIn profile is https://www.linkedin.com/company/xenotherapeutics
Xenotherapeutics has
13 employees.
View email and phone details for 13
employees at Xenotherapeutics.
Xenotherapeutics's industry is
Biotechnology Research
Xenotherapeutics's top competitors are
Cytoink,
Viscus Biologics Llc,
Avellino,
Wofford Advisors,
Pro Therapeutics,
Frontier Bio,
Aptus Bioreactors,
Essa Pharma,
Asclepii,
Cryostasis.
Xenotherapeutics's categories are Biotechnology Research
Xenotherapeutics's founding year is 2016
